{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:09:07Z","timestamp":1778022547455,"version":"3.51.4"},"reference-count":21,"publisher":"Begell House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Long Term Eff Med Implants"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>This study utilizes an all-payer database to compare 90-d and 1-year outcomes between marijuana and non-marijuana users undergoing total hip arthroplasty (THA). The primary aim of this study focused on 90-d and 1-year opioid consumption among marijuana users and non-users who underwent THA. Our secondary aim focused on comparing 90-d and 1-year rates of readmissions, revisions and adverse events between the two groups. A retrospective review was performed in the Mariner Database for all primary THA patients from 2010 to 2018. Marijuana users were identified utilizing International Classification of Diseases (ICD) 9 and 10 codes and matched 1:1 to non-marijuana users on age, sex, Charlson Comorbidity Index (CCI), obesity, alcohol, tobacco, illicit drug use, history of drug abuse, and presence of psychiatric history. This yielded a total of 1654 patients in each group. The 90-d and 1-year outcomes included opioid consumption, episode of care costs, readmissions, revisions, and complications. Chi-square was employed to assess categorical variables, while &lt;i&gt;t&lt;\/i&gt;-tests were employed for continuous variables. There was no difference in opioid consumption among marijuana users and non-marijuana users who underwent a THA. Marijuana use was associated with lower 90-d costs of care when compared with non-marijuana users. Marijuana users had higher rates of hip dislocation within 90 d and 1 year of surgery. Marijuana use is associated with higher 90-d and 1-year dislocation rates. THA recipients who use marijuana should be counseled concerning this increased risk. Prospective randomized control trials are needed to verify the results of this study.\n<\/p>","DOI":"10.1615\/jlongtermeffmedimplants.2024049017","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T22:02:03Z","timestamp":1708466523000},"page":"17-23","source":"Crossref","is-referenced-by-count":2,"title":["Marijuana Use Is Associated with Increased Rates of Hip Dislocation and Lower Insurance Reimbursement among Total Hip Arthroplasty Recipients"],"prefix":"10.1615","volume":"35","author":[{"given":"Chukwuweike","family":"Gwam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Recker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes F.","family":"Plate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Keyhani S, Steigerwald S, Ishida J, Vali M, Cerda M, Hasin D, Dollinger C, Yoo S, Cohen B. Risks and benefits of marijuana use a national survey of U.S. adults. Ann Intern Med. 2018;169(5):282-90.","DOI":"10.7326\/M18-0810"},{"key":"2","unstructured":"Dorbian I. New cannabis report predicts legal sales to reach nearly $30 billion by 2025. Forbes, Forbes Magazine, 26 Feb 2024. Available from: www.forbes.com\/sites\/irisdorbian\/2019\/09\/24\/new-cannabis-report-predicts-legal-sales-to-reach-nearly-30-billion-by-2025\/."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Han BH, Palamar JJ. Trends in cannabis use among older adults in the United States, 2015-2018. JAMA Intern Med. 2020;180(4):609-11.","DOI":"10.1001\/jamainternmed.2019.7517"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bonn-Miller MO, Sisley S, Riggs P, Yazar-Klosinski B, Wang JB, Loflin MJE, Schechet B, Hennigan C, Matthews R, Emerson A, Doblin R. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. Le Foll B, editor. PLoS One. 2021;16(3):e0246990.","DOI":"10.1371\/journal.pone.0246990"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Babalonis S, Walsh SL. Therapeutic potential of opioid\/cannabinoid combinations in humans: Review of the evidence. Eur Neuropsychopharmacol. 2020;36:206-16.","DOI":"10.1016\/j.euroneuro.2020.03.002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Baron EP. Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: An update on current evidence and cannabis science. Headache. 2018;58(7): 1139-86.","DOI":"10.1111\/head.13345"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Lowe H, Steele B, Bryant J, Toyang N, Ngwa W. Non-cannabinoid metabolites of Cannabis sativa L. with therapeutic potential. Plants. 2021;10(2):400.","DOI":"10.3390\/plants10020400"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Maayah ZH, Takahara S, Ferdaoussi M, Dyck JRB. The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis. Inflamm Res. 2020;69(6):549-58.","DOI":"10.1007\/s00011-020-01341-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Bondarenko AI. Cannabinoids and cardiovascular system. Adv Exp Med Biol. 2019:1162:63-87.","DOI":"10.1007\/978-3-030-21737-2_5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Pacher P, Batkai S, Kunos G. Blood pressure regulation by endocannabinoids and their receptors. Neuropharmacology. 2005;48(8):1130-8.","DOI":"10.1016\/j.neuropharm.2004.12.005"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Vuckovic S, Srebro D, Vujovic KS, Vucetic C, Prostran M. Cannabinoids and pain: New insights from old molecules. Front Pharmacol. 2018:9:1259.","DOI":"10.3389\/fphar.2018.01259"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Nielsen S, Picco L, Murnion B, Winters B, Matheson J, Graham M, Campbell G, Parvaresh L, Kohr K, Bretz B, Farrell M, Lintzeris N, Le Foll B. Opioid-sparing effect of cannabinoids for analgesia: An updated systematic review and meta-analysis of preclinical and clinical studies. Neuropsychopharmacology. 2022;47(7):1315-30.","DOI":"10.1038\/s41386-022-01322-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Piano MR. Cannabis smoking and cardiovascular health: It's complicated. Clin Pharmacol Ther. 2017; 102(2):191-3.","DOI":"10.1002\/cpt.721"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Manolis TA, Manolis AA, Manolis AS. Cannabis associated 'high' cardiovascular morbidity and mortality: Marijuana smoke like tobacco smoke? A deja vu\/deja vecu story? Mini Rev Med Chem. 2019;19(11):870-9.","DOI":"10.2174\/1389557518666181114113947"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Goel A, McGuinness B, Jivraj NK, Wijeysundera DN, Mittleman MA, Bateman BT, Clark H, Kotra L, Ladha K. Cannabis use disorder and perioperative outcomes in major elective surgeries: A retrospective cohort analysis. Anesthesiology. 2020;132(4):625-35.","DOI":"10.1097\/ALN.0000000000003067"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624-1645. doi: 10.1001\/jama.2016.1464.","DOI":"10.1001\/jama.2016.1464"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain-United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Moon AS, Smith W, Mullen S, Ponce BA, McGwin G, Shah A, Naranje S. Marijuana use and mortality following orthopedic surgical procedures. Subst Abus. 2019;40(3):378-82.","DOI":"10.1080\/08897077.2018.1449054"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Runner RP, Luu AN, Thielen ZP, Scudday TS, Nassif NA, Patel JJ, Barnett S, Gorab R. Opioid use after discharge following primary unilateral total knee arthroplasty: How much are we over-prescribing? J Arthroplasty. 2020;35(6):S158-62.","DOI":"10.1016\/j.arth.2020.01.078"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Olah T, Bodnar D, Toth A, Vincze J, Fodor J, Reischl B, Kovachs A, Ruzsnavszky O, Dienes B, Szentesi P, Friedrich O, Csernoch L. Cannabinoid signalling inhibits sarcoplasmic Ca2+ release and regulates excitation-contraction coupling in mammalian skeletal muscle. J Physiol. 2016;594(24):7381-98.","DOI":"10.1113\/JP272449"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Bradford AC, Bradford WD. Medical marijuana laws reduce prescription medication use in medicare part D. Health Aff (Millwood). 2016;35(7):1230-6.","DOI":"10.1377\/hlthaff.2015.1661"}],"container-title":["Journal of Long-Term Effects of Medical Implants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/11d9f5750479004f\/JLT-49017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T05:37:58Z","timestamp":1734673078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/1bef42082d7a0fdf,4043ec681fa7a41a,11d9f5750479004f.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/jlongtermeffmedimplants.2024049017","relation":{},"ISSN":["1050-6934"],"issn-type":[{"value":"1050-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}